CBmed Email Formats

Research Services • Graz, Styria, Austria • 51-100 Employees

CBmed Email Formats

CBmed uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cbmed.at), used 72.2% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cbmed.at	72.2%
{first initial}.{last name}	j.doe@cbmed.at	27.8%

Key Contacts at CBmed

Robert Lobnig

Ceo

Riga Tawo

Scientific Director

Laurin Herbsthofer

Director Of It And Data Science

Angela Jacan

Director Of People And Culture

Company overview

Headquarters	Stiftingtalstraße 14, Graz, Styria 8010, AT
Phone number	+4331638528801
Website	cbmed.at
NAICS	5417
SIC	873
Keywords	Oncology, Mass Spectrometry, Precision Medicine, Digital Pathology, Immunology, Microbiome, Metabolomics, Drug Screening, Personalised Medicine, Biomarker
Founded	2014
Employees	51-100
Socials

About CBmed

Founded in 2014, CBmed is a clinical and biomedical research center dedicated to advancing translational medicine. By seamlessly connecting scientific discoveries with patient care, we integrate world-class research infrastructure, scientific expertise, medical knowledge, and strategic partnerships with industry leaders both nationally and internationally. This innovative approach positions CBmed at the forefront of precision medicine, transforming therapeutic strategies beyond traditional one-size-fits-all models. Our core strength lies in combining state-of-the-art research infrastructure with strong connections to leading biobanks, including Europe’s largest, Biobank Graz, and the European Biobank Network BBMRI-ERIC. These collaborations enable us to identify and validate new biomarkers and advance translational research for real-world clinical applications. CBmed’s cutting-edge technologies offer comprehensive, multi-platform analyses for a deeper understanding of biomarker research. By integrating multi-omics data from various sources, we create synergies that directly contribute to clinical decision support. Our expertise in multi-omics research, coupled with Total Quality Management and advanced Lab Information and Management Systems (LIMS), ensures precise and rigorous documentation of all lab processes, from sample tracking to final reporting. This commitment to accuracy, personalization, and quality reflects our dedication to advancing healthcare research. CBmed’s revolutionary ex-vivo compound screening platform, which uses patient-derived tumor spheroids, allows us to assess the effectiveness of therapeutic agents for individual patients. This approach not only enables personalized treatment strategies but also accelerates drug development for our industry partners. At CBmed, we are at the cutting edge of biomarker research, using our unique position and collaborations to drive innovations that have a lasting impact on patient care and cure.